Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
149
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Analysis of Risk Factors for Carbapenem Resistant Klebsiella pneumoniae Infection and Construction of Nomogram Model: A Large Case-Control and Cohort Study from Shanxi, China

Hongwei Wang1 Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaView further author information
,
Fangying Tian2 Infection Management Department of the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Xueyu Wang3 Department of Infectious Diseases, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaView further author information
,
Ming Zhao1 Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaView further author information
,
Ruiqin Gao1 Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaView further author information
&
Xinyu Cui1 Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of ChinaView further author information
Pages 7351-7363 | Received 02 Oct 2023, Accepted 22 Nov 2023, Published online: 29 Nov 2023

References

  • Wang M, Earley M, Chen L, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet. 2022;22(3):401–412. doi:10.1016/S1473-3099(21)00399-6
  • Wu Y, Wu C, Bao D, et al. Global evolution and geographic diversity of hypervirulent carbapenem-resistant Klebsiella pneumoniae. Lancet Infect Dis. 2022;22(6):761–762. doi:10.1016/S1473-3099(22)00275-4
  • Changes of drug resistance of Klebsiella pneumoniae to imipenem and meropenem. Institute of antibiotics, Huashan Hospital, Fudan University, China. Available from: http://www.chinets.com/Data/GermYear. Accessed September 9, 2023.
  • Lou T, Du X, Zhang P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case-control and cohort study. J Infect. 2022;84(5):637–647. doi:10.1016/j.jinf.2022.03.010
  • Çölkesen F, Tarakçı A, Eroğlu E, et al. Carbapenem-resistant Klebsiella pneumoniae infection and its risk factors in older adult patients. Clin Interv Aging. 2023;18:1037–1045. doi:10.2147/CIA.S406214
  • Candevir Ulu A, Kurtaran B, Inal AS, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015;21:219–224. doi:10.12659/MSM.892516
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Thirty-First Informational Supplement. Wayne PA: CLSI; 2021.
  • Hospital infection surveillance standards. National Health Commission of the People’s Republic of China. Available from: http://www.nhc.gov.cn/wjw/s9496/202309/432d0f9af63443e890019af57afaf853.shtml. Accessed September 9, 2023.
  • Chinese Expert Consensus on Diagnosis, Treatment, Prevention and Control of Carbapenem-Resistant Enterobacteriaceae Bacterial Infections, China Medical Education Association Infectious Diseases Committee, Chinese Medical Association Bacterial Infections and Drug-Resistant Infections Prevention and Control Committee. Expert consensus on diagnosis, treatment, prevention and control of carbapenem-resistant Enterobacteriaceae bacterial infections in China. Chinese Med J. 2021;101(36):2850–2860. doi:10.3760/cma.j.cn112137-20210219-00438.
  • Kidd AC, McGettrick M, Tsim S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respir Res. 2018;5(1):e000240. doi:10.1136/bmjresp-2017-000240
  • Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. World Health Organization; 2017. Available from: https://www.who.int/publications/i/item/9789241550178. Accessed November 27, 2023.
  • Wang YP, Chen YH, Hung IC, et al. Transporter genes and fosa associated with fosfomycin resistance in carbapenem-resistant Klebsiella pneumoniae. Front Microbiol. 2022;13:816806. doi:10.3389/fmicb.2022.816806
  • Yang J, Zhang K, Ding C, Wang S, Wu W, Liu X. Exploring multidrug-resistant Klebsiella pneumoniae antimicrobial resistance mechanisms through whole genome sequencing analysis. BMC Microbiol. 2023;23(1):245. doi:10.1186/s12866-023-02974-y
  • Zhou S, Ren G, Liu Y, et al. Challenge of evolving Klebsiella pneumoniae infection in patients on hemodialysis: from the classic strain to the carbapenem-resistant hypervirulent one. Int J Med Sci. 2022;19(3):416–424. doi:10.7150/ijms.69577
  • Zhang F, Zhong J, Ding H, et al. Analysis of risk factors for carbapenem-resistant Klebsiella pneumoniae infection and its effect on the outcome of early infection after kidney transplantation. Front Cell Infect Microbiol. 2021;11:726282. doi:10.3389/fcimb.2021.726282
  • Yu R, Li L, Zou C, et al. Emergence of high-level tigecycline resistance due to the amplification of a tet(A) gene variant in clinical carbapenem-resistant Klebsiella pneumoniae. Clin Microbiol Infect. 2023;29(11):1452–e1. doi:10.1016/j.cmi.2023.07.030
  • Ni W, Han Y, Liu J, et al. Tigecycline treatment for carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Medicine. 2016;95(11):e3126. doi:10.1097/MD.0000000000003126

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.